Associated Papers
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial.
Rosenson RS et al.
Nature Medicine, 2023
36879129 (PubMed )
Supplement: 41591_2023_2222_MOESM1_ESM.pdf
A subregion-based burden test for simultaneous identification of susceptibility loci and subregions within.
Zhu B et al.
Genetic Epidemiology, 2018
iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.
Wang M et al.
Scientific Reports, 2016
27527004 (PubMed )
Supplement: srep31321-s3.xls › NovelVar
Beyond Rare-Variant Association Testing: Pinpointing Rare Causal Variants in Case-Control Sequencing Study.
Lin WY
Scientific Reports, 2016
Identification of rare causal variants in sequence-based studies: methods and applications to VPS13B, a gene involved in Cohen syndrome and autism.
Ionita-Laza I et al.
Plos Genetics, 2014
Phylogenetics applied to genotype/phenotype association and selection analyses with sequence data from angptl4 in humans.
Maxwell TJ et al.
International Journal of Molecular Sciences, 2010
Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.
Romeo S et al.
The Journal of Clinical Investigation, 2009
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
Romeo S et al.
Nature Genetics, 2007
Select a paper to view details